Julia Stockmann

Amyloid‐beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years

D. Rujescu, K. Gerwert, B. Holleczek, 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Discovery of three novel sesquiterpene synthases from Streptomyces chartreusis NRRL 3882 and crystal structure of an α-eudesmol synthase.

J. Bandow, D. Logan, R. Kourist, 2019, Journal of biotechnology.

Transcriptome profiling of the Australian arid-land plant Eremophila serrulata (A.DC.) Druce (Scrophulariaceae) for the identification of monoterpene synthases.

J. Kalinowski, T. Brück, M. Piotrowski, 2017, Phytochemistry.

Amyloid-β misfolding as a plasma biomarker indicates risk for future clinical Alzheimer’s disease in individuals with subjective cognitive decline

W. M. van der Flier, P. Scheltens, K. Gerwert, 2020, Alzheimer's research & therapy.

Association of plasma biomarkers, p‐tau181, glial fibrillary acidic protein, and neurofilament light, with intermediate and long‐term clinical Alzheimer's disease risk: Results from a prospective cohort followed over 17 years

D. Rujescu, B. Schöttker, K. Beyreuther, 2022, Alzheimer's & dementia : the journal of the Alzheimer's Association.

Genetic predisposition, Aβ misfolding in blood plasma, and Alzheimer’s disease

D. Rujescu, A. Hartmann, H. Brenner, 2021, Translational Psychiatry.

The Effect of (-)-Epigallocatechin-3-Gallate on the Amyloid-β Secondary Structure.

K. Gerwert, J. Gumbart, V. Batista, 2020, Biophysical journal.